<DOC>
	<DOCNO>NCT03050749</DOCNO>
	<brief_summary>In study , eligible patient medical indication ( facial lipoatrophy , morphological asymmetry face , debilitate scar ) treat Princess® VOLUME , return follow-up assessment 2 , 4 , 24 , 36 week treatment . A touch-up treatment may do 2 week treatment deem appropriate Investigator .</brief_summary>
	<brief_title>Safety Performance Princess® VOLUME Treatment Facial Lipoatrophy , Asymmetry Scars</brief_title>
	<detailed_description />
	<mesh_term>Facies</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>Male female 18 year age old Presence defect , opinion Investigator correct dermal filler , cause : ° Facial lipoatrophy moderate severity , Morphological asymmetry face , One debilitating scar face Willingness abstain cosmetic surgical procedure treatment area duration clinical investigation Willingness take part clinical investigation evidence personally sign informed consent . Pregnancy , breastfeeding , unwillingness use contraception throughout clinical investigation ( woman childbearing potential ) History allergic reaction hypersensitivity hyaluronic acid History presence autoimmune connective tissue disease , current treatment immune therapy Presence silicone implant nonabsorbable tissue filler area target intervention , pretreatment hyaluronic acid filler within last six month Presence infectious , inflammatory , proliferative lesion area target intervention Treatment anticoagulant antiplatelet drug Any disease condition , Investigator 's opinion , represent safety risk participation study Current participation another clinical trial , previous treatment investigational drug/device within 30 day prior enrolment Institutionalized person legally limit civil right</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>